Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 11, 2011 - Issue 11
Submit an article Journal homepage
1,527
Views
20
CrossRef citations to date
0
Altmetric
Review

Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas

Serena Pellegatta Fondazione I.R.C.C.S Istituto Neurologico C. Besta, Via Celoria 11, 20133 Milan, Italy; IFOM-IEO Campus, Milan, Italy; Fondazione I.R.C.C.S Istituto Neurologico C. Besta, Via Celoria 11, 20133 Milan, Italy; IFOM-IEO Campus, Milan, Italy
,
Lucia Cuppini Fondazione I.R.C.C.S Istituto Neurologico C. Besta, Via Celoria 11, 20133 Milan, Italy; Fondazione I.R.C.C.S Istituto Neurologico C. Besta, Via Celoria 11, 20133 Milan, Italy
&
Gaetano Finocchiaro Fondazione I.R.C.C.S Istituto Neurologico C. Besta, Via Celoria 11, 20133 Milan, Italy; IFOM-IEO Campus, Milan, Italy;[email protected]
Pages 1759-1774 | Published online: 10 Jan 2014

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Vaishali Y. Londhe & Varada Date. (2020) Personalized neoantigen vaccines: a glimmer of hope for glioblastoma. Expert Review of Vaccines 19:5, pages 407-417.
Read now
Mayuri Chandran, Marianela Candolfi, Diana Shah, Yohei Mineharu, Viveka Nand Yadav, Carl Koschmann, Antonela S. Asad, Pedro R. Lowenstein & Maria G. Castro. (2017) Single vs. combination immunotherapeutic strategies for glioma. Expert Opinion on Biological Therapy 17:5, pages 543-554.
Read now
Sara Ferluga & Waldemar Debinski. (2014) Ephs and Ephrins in malignant gliomas. Growth Factors 32:6, pages 190-201.
Read now
Gabriele Cantini, Federica Pisati, Sara Pessina, Gaetano Finocchiaro & Serena Pellegatta. (2012) Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity. OncoImmunology 1:6, pages 884-893.
Read now

Articles from other publishers (16)

Sara Hanaei, Víctor Andrés Arrieta & Adam M. Sonabend. 2020. Cancer Immunology. Cancer Immunology 379 425 .
Satsuki Miyata, Kaoru Tominaga, Eiji Sakashita, Masashi Urabe, Yoshiyuki Onuki, Akira Gomi, Takashi Yamaguchi, Makiko Mieno, Hiroaki Mizukami, Akihiro Kume, Keiya Ozawa, Eiju Watanabe, Kensuke Kawai & Hitoshi Endo. (2019) Comprehensive Metabolomic Analysis of IDH1R132H Clinical Glioma Samples Reveals Suppression of β-oxidation Due to Carnitine Deficiency. Scientific Reports 9:1.
Crossref
Irene Appolloni, Francesco Alessandrini, Davide Ceresa, Daniela Marubbi, Eleonora Gambini, Daniele Reverberi, Fabrizio Loiacono & Paolo Malatesta. (2019) Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting. Cancer Letters 442, pages 213-221.
Crossref
Kalaivani Kalamohan, Dhanasekaran Rathinam, Ponmathi Panneerpandian & Kumaresan Ganesan. (2017) Coexpressed modular gene expression reveals inverse correlation between immune responsive transcription and aggressiveness in gastric tumours. Cancer Immunology, Immunotherapy 66:7, pages 941-954.
Crossref
P. Roth & M. Weller. 2017. Translational Immunotherapy of Brain Tumors. Translational Immunotherapy of Brain Tumors 213 226 .
Christina N. Lessov-Schlaggar, Joshua B. Rubin & Bradley L. Schlaggar. (2016) The Fallacy of Univariate Solutions to Complex Systems Problems. Frontiers in Neuroscience 10.
Crossref
Na Tosha N Gatson, Shiao-Pei S Weathers & John F de Groot. (2016) ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma (retracted). CNS Oncology 5:1, pages 11-26.
Crossref
Mario Orozco-Morales, Francisco Javier Sánchez-García, Irene Golán-Cancela, Norma Hernández-Pedro, Jose A. Costoya, Verónica Pérez de la Cruz, Sergio Moreno-Jiménez, Julio Sotelo & Benjamín Pineda. (2015) RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells. Cancer Cell International 15:1.
Crossref
Jun Yan, Ling-Yuan Kong, Jiemiao Hu, Konrad Gabrusiewicz, Denada Dibra, Xueqing Xia, Amy B. Heimberger & Shulin Li. (2015) FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. JNCI: Journal of the National Cancer Institute 107:8.
Crossref
Adam M. Sonabend, Christopher R. Showers & Richard C. E. Anderson. 2015. Cancer Immunology. Cancer Immunology 333 362 .
Sergiy V. Kushchayev, Yevgeniya S. Kushchayeva, Philip C. Wiener, Adrienne C. Scheck, Behnam Badie & Mark C. Preul. (2014) Monocyte-Derived Cells of the Brain and Malignant Gliomas: The Double Face of Janus. World Neurosurgery 82:6, pages 1171-1186.
Crossref
P. Roth & M. Weller. (2014) Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies. Neuro-Oncology 16:suppl 8, pages viii14-viii19.
Crossref
Eli T. Sayegh, Taemin Oh, Shayan Fakurnejad, Orin Bloch & Andrew T. Parsa. (2014) Vaccine therapies for patients with glioblastoma. Journal of Neuro-Oncology 119:3, pages 531-546.
Crossref
Gilson S. Baia, Otavia L. Caballero, Janelle S.Y. Ho, Qi Zhao, Tzeela Cohen, Zev A. Binder, Vafi Salmasi, Gary L. Gallia, Alfredo Quinones-Hinojosa, Alessandro Olivi, Henry Brem, Peter Burger, Robert L. Strausberg, Andrew J.G. Simpson, Charles G. Eberhart & Gregory J. Riggins. (2013) NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches. Cancer Immunology Research 1:5, pages 296-302.
Crossref
H.F. van Thuijl, B. Ylstra, T. Würdinger, D. van Nieuwenhuizen, J.J. Heimans, P. Wesseling & J.C. Reijneveld. (2013) Genetics and pharmacogenomics of diffuse gliomas. Pharmacology & Therapeutics 137:1, pages 78-88.
Crossref
K Oleinika, R J Nibbs, G J Graham & A R Fraser. (2013) Suppression, subversion and escape: the role of regulatory T cells in cancer progression. Clinical and Experimental Immunology 171:1, pages 36-45.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.